Home › Funds › Marathon Trading Investment Management LLC › SLS
Marathon Trading Investment Management LLC position in SLS
SELLAS LIFE SCIENCES GROUP I · Health Care
Marathon Trading Investment Management LLC reported holding 50,100 shares of SLS (SELLAS LIFE SCIENCES GROUP I) in its Q3 2026 13F filing — a position valued at US$617K, representing 0.11% of its reported portfolio and ranking #49 among its reported holdings. Marathon Trading Investment Management LLC has disclosed SLS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Marathon Trading Investment Management LLC's SLS position evolved
Marathon Trading Investment Management LLC first disclosed a stake in SLS in Q4 2025 at 114,600 shares (US$432K). The position peaked in Q3 2026 at 50,100 shares, worth US$617K. Across 4 filings, Marathon Trading Investment Management LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 50,100 shares valued at US$617K — an increase of 40,100 shares quarter over quarter.. Notable position changes include a 99% trim in Q1 2026 (shares rose 249% over the following quarter), a 740% increase in Q2 2026 (shares fell 17% over the following quarter), a 401% increase in Q3 2026 (shares fell 36% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 114.60K | $432.04K | New |
| Q1 2026 | 1.19K | $5.04K | Reduce |
| Q2 2026 | 10.00K | $147.60K | Add |
| Q3 2026 | 50.10K | $616.73K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLS and 13F data
SLS (SELLAS LIFE SCIENCES GROUP I) is a Health Care company. 106 other funds we track also report a position in SLS — the largest reported positions include Sio Capital Management, LLC (US$18.2M), DAGCO, INC. (US$16.5M), Anson Funds Management LP (US$11.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLS
- Sio Capital Management, LLC 1.23M sh · $18.17M · Q2 2026
- DAGCO, INC. 1.34M sh · $16.45M · Q3 2026
- Anson Funds Management LP 800.00K sh · $11.81M · Q2 2026
- Ikarian Capital, LLC 354.70K sh · $5.24M · Q2 2026
- Opus Capital Group, LLC 403.63K sh · $4.97M · Q3 2026
- Rosalind Advisors, Inc. 568.70K sh · $2.30M · Q2 2026
- FULCRUM WEALTH ADVISORS, LLC 85.45K sh · $1.05M · Q3 2026
- VISION FINANCIAL MARKETS LLC 57.00K sh · $701.67K · Q3 2026
- INSTRUMENTAL WEALTH, LLC 44.91K sh · $552.89K · Q3 2026
More on Marathon Trading Investment Management LLC
FAQ
How long has Marathon Trading Investment Management LLC held SLS?
Marathon Trading Investment Management LLC has disclosed SLS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Marathon Trading Investment Management LLC's current position in SLS?
As of Q3 2026, Marathon Trading Investment Management LLC holds 50.10K shares of SLS (SELLAS LIFE SCIENCES GROUP I), valued at $616.73K, representing 0.11% of its reported portfolio and ranking #49.
Has Marathon Trading Investment Management LLC been buying or selling SLS?
In the latest 13F filing (Q3 2026), Marathon Trading Investment Management LLC increased its position in SLS. The position peaked in Q3 2026 at 50.10K shares.
Which other funds hold SLS?
Other major institutional holders of SLS include Sio Capital Management, LLC, DAGCO, INC., Anson Funds Management LP, among 106 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.